Intravenous Infusions PLC reported unaudited financial results for the period ended September 30, 2016. For the period, the company reported revenue of GHC 7,433,207 against GHC 5,528,352 a year ago. Operating profit before interest and tax was GHC 1,460,151 compared to GHC 453,159 a year ago. Profit before tax was GHC 1,095,632 compared to loss of GHC 83,095 a year ago. Net profit for the year was GHC 890,201 against loss of GHC 83,095 a year ago. Net cash used in operating activities was GHC 4,570,599 compared to GHC 237,135 a year ago. Purchase of property, plant and equipment was GHC 562,181 compared to GHC 47,477 a year ago.